Our Insights Oncology Anthony Iannacci 4/7/26 Oncology Anthony Iannacci 4/7/26 Lifyorli Approved in Platinum-Resistant Ovarian Cancer Thanks to a 35% Reduction in Mortality Read More Want to get in touch? Click here
Oncology Anthony Iannacci 4/7/26 Oncology Anthony Iannacci 4/7/26 Lifyorli Approved in Platinum-Resistant Ovarian Cancer Thanks to a 35% Reduction in Mortality Read More